Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Appili Therapeutics Inc.    APLI   CA03783R1073

APPILI THERAPEUTICS INC.

(APLI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Appili Therapeutics : Appli Therapeutics Up 3% As Consortium Files Application for Reeqonus to Treat COVID-19 Under Health Canada Interim Order

12/22/2020 | 09:47am EST


© MT Newswires 2020
All news about APPILI THERAPEUTICS INC.
02/26APPILI THERAPEUTICS : to Host Drs. Scott Gottlieb and Syra Madad in Virtual Fire..
AQ
02/25APPILI THERAPEUTICS : to Present as Part of Canada's Top Three Pitches at Biocom..
AQ
02/25APPILI THERAPEUTICS TO HOST DRS. SCO : What We've Learned About Pandemic Respons..
BU
02/24APPILI THERAPEUTICS : to Present as Part of Canada's Top Three Pitches at Biocom..
BU
02/19APPILI THERAPEUTICS : to Host Series of Virtual Fireside Chats, First Event to F..
AQ
02/18APPILI THERAPEUTICS : to Host Series of Virtual Fireside Chats; First Event to F..
BU
02/15APPILI THERAPEUTICS : Reports Financial and Operational Results for Third Quarte..
AQ
02/12APPILI THERAPEUTICS : Reports Financial and Operational Results for Third Quarte..
BU
02/02APPILI THERAPEUTICS : Appoints Veteran Healthcare Executive Rochelle Stenzler to..
BU
01/28APPILI THERAPEUTICS : Provides Update on Phase 3 Trial Evaluating Oral Antiviral..
MT
More news
Financials
Sales 2021 0,02 M 0,02 M 0,02 M
Net income 2021 -12,6 M -9,91 M -9,91 M
Net Debt 2021 - - -
P/E ratio 2021 -5,22x
Yield 2021 -
Capitalization 67,0 M 52,7 M 52,5 M
Capi. / Sales 2021 2 743x
Capi. / Sales 2022 2,18x
Nbr of Employees -
Free-Float 100%
Chart APPILI THERAPEUTICS INC.
Duration : Period :
Appili Therapeutics Inc. Technical Analysis Chart | APLI | CA03783R1073 | MarketScreener
Technical analysis trends APPILI THERAPEUTICS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 2,37 CAD
Last Close Price 1,07 CAD
Spread / Highest target 157%
Spread / Average Target 121%
Spread / Lowest Target 49,5%
EPS Revisions
Managers and Directors
NameTitle
Armand L. Balboni Chief Executive Officer & Director
Kimberly Stephens Chief Financial Officer & Secretary
Ian C. Mortimer Chairman
Yoav Golan Chief Medical Officer
Theresa Matkovits Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
APPILI THERAPEUTICS INC.-12.30%53
GILEAD SCIENCES, INC.7.78%76 967
VERTEX PHARMACEUTICALS-10.07%55 255
WUXI APPTEC CO., LTD.6.65%53 955
REGENERON PHARMACEUTICALS-6.19%46 924
BEIGENE, LTD.23.84%29 313